AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q
By Sabela Ojea Shares of AbbVie lost 4.6% to close at $159.62 on Friday after the company warned about the effects of losing the exclusivity of its patent for the arthritis medication Humira,...
Source: marketscreener.com